EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial‐Associated Biomarker in Pancreatic Cancer

Wanliang Sun, Yifei Wang, Xuxu Qiao, Shuo Zhou iD, Zhong Liu, Song Yang, Dengyong Zhang, Dongdong Wang, Hu Zhou, Feiyu Qi, Mingrui Zhang, Binquan Wu und 3 weitere

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/5510306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 06.05.2026. Verfasst von Wanliang Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China, bbmc.edu.cn. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Pancreatic Neoplasms, Mitochondria, Biomarkers, Tumor. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is characterized by aggressive biological behavior and limited therapeutic responsiveness. Identifying genetically and biologically interpretable biomarkers remains critical for improving molecular stratification of this malignancy. Here, we performed an integrative analysis combining bulk transcriptomics, genomic alteration profiling, immune‐response modeling, and functional validation to characterize the clinical relevance of voltage‐dependent anion channel 1 (VDAC1) in PDAC. Genomic analyses demonstrated that VDAC1 exhibits a low somatic mutation frequency in PDAC and that its dysregulated expression may be partly associated with copy number alterations. Transcriptomic analyses further showed that VDAC1 is significantly upregulated in tumor tissues and associated with unfavorable clinical outcomes. Multiomics characterization indicated that high VDAC1 expression is linked to mitochondrial metabolic programs and reduced cytotoxic immune signatures. Functional validation demonstrated that VDAC1 silencing impaired pancreatic cancer cell proliferation and disrupted mitochondrial homeostasis, including reduced mitochondrial membrane potential, ATP production, and mitochondrial reactive oxygen species levels. In addition, VDAC1 perturbation reduced immunosuppressive cytokine output, suggesting a tumor‐intrinsic connection between mitochondrial metabolic regulation and immune‐related programs. Collectively, this study provides a genomic alteration‐informed multiomics framework supporting VDAC1 as a mitochondrial‐associated biomarker in PDAC and highlights its potential relevance for molecular characterization of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1Pancreatic NeoplasmsMitochondriaBiomarkers, TumorGenomicsCarcinoma, Pancreatic DuctalHumansMultiomicsGene Expression Regulation, NeoplasticMutationGene Expression ProfilingCell Line, TumorDNA Copy Number VariationsCell Proliferation

Stichwörter der Autor:innen

VDAC1copy number variationgenomic alterationsmitochondrial metabolismmultiomics integrationpancreatic ductal adenocarcinomaprognostic biomarker

Substanzen

Voltage-Dependent Anion Channel 1Biomarkers, TumorVDAC1 protein, human

Autor:innen und Institutionen

  • Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China, bbmc.edu.cn.
  • Department of Cardiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China, bbmc.edu.cn.
  • Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China, bbmc.edu.cn.
  • School of Medicine, Nankai University, Tianjin, China, nankai.edu.cn.
  • School of Medicine, Bengbu Medical University, Bengbu, China, bbmc.edu.cn.
  • Department of Transfusion Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China, gxyyfy.cn.

ORCID-Profile: Shuo Zhou, Yi Tan, Lijun Cen, Biao Zhang

Förderung

  • Anhui Provincial Department of Education

Zitieren

APA

Sun, W., Wang, Y., Qiao, X., Zhou, S., Liu, Z., Yang, S., Zhang, D., Wang, D., Zhou, H., Qi, F., Zhang, M., Wu, B., Tan, Y., Cen, L., & Zhang, B. (2026). Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial‐Associated Biomarker in Pancreatic Cancer. Human Mutation, 2026(1). https://doi.org/10.1155/humu/5510306

Vancouver

Sun W, Wang Y, Qiao X, Zhou S, Liu Z, Yang S, et al. Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial‐Associated Biomarker in Pancreatic Cancer. Human Mutation. 2026;2026(1). doi:10.1155/humu/5510306

BibTeX
@article{Sun2026,
  author = {Sun, Wanliang and Wang, Yifei and Qiao, Xuxu and Zhou, Shuo and Liu, Zhong and Yang, Song and Zhang, Dengyong and Wang, Dongdong and Zhou, Hu and Qi, Feiyu and Zhang, Mingrui and Wu, Binquan and Tan, Yi and Cen, Lijun and Zhang, Biao},
  title = {Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial‐Associated Biomarker in Pancreatic Cancer},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/5510306}
}
Kostenlos starten →